Read + Share
Amedeo Smart
Independent Medical Education
. Trastuzumab deruxtecan beats trastuzumab emtansine in lowered disease progression, death. Cancer 2022;128:2852.PMID: 35797061
Email
LinkedIn
Facebook
Twitter
Privacy Policy